Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapies.
Schwake C, Pakeerathan T, Kleiter I, Ringelstein M, Aktas O, Korporal-Kuhnke M, Wildemann B, Jarius S, Bayas A, Pul R, Ceylan U, Faissner S, Hellwig K, Ayroza Galvao Ribeiro Gomes AB, Lipps P, Pröbstel AK, Kümpfel T, Oswald E, Then Bergh F, Gödel C, Hümmert MW, Trebst C, Gold R, Ayzenberg I. Schwake C, et al. Among authors: pul r. Mult Scler. 2023 May;29(6):757-761. doi: 10.1177/13524585221151124. Epub 2023 Feb 7. Mult Scler. 2023. PMID: 36748649 Free PMC article.
[Consensus recommendations on regional interdisciplinary standardization of MRI diagnostics for multiple sclerosis in the metropolitan area of Essen].
Stettner M, Wattjes MP, Krüger K, Pul R, Fleischer M, Achnitz U, Agne H, Bach K, Berkenfeld R, Bongartz U, Brüggemann A, Burgsmüller L, Cohnen J, Deuschl C, Friedrich A, Graziano P, Hackert J, Hapig B, Henkel A, Henrich H, Hükelheim-Görden M, Kratsch L, Kytzia D, Lanzman R, Heusch P, Laufenburg C, Merguet S, Metz U, Montag M, Obeid M, Ornek A, Peters S, Plajer T, Plassmann J, Pump H, Rauchfuss-Hartych B, Reinboldt MP, Seng K, Stauder M, Wettig AK, Wolters A, Yilmam S, Kleinschnitz C. Stettner M, et al. Among authors: pul r. Nervenarzt. 2023 Dec;94(12):1123-1128. doi: 10.1007/s00115-023-01531-2. Epub 2023 Aug 18. Nervenarzt. 2023. PMID: 37594495 Free PMC article. Review. German.
Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany - Baseline characteristics of the POWER@MS1 randomised controlled trial.
Krause N, Derad C, von Glasenapp B, Riemann-Lorenz K, Temmes H, van de Loo M, Friede T, Asendorf T, Heesen C; POWER@MS1 study group. Krause N, et al. Mult Scler Relat Disord. 2023 Nov;79:105043. doi: 10.1016/j.msard.2023.105043. Epub 2023 Oct 5. Mult Scler Relat Disord. 2023. PMID: 37839367 Free article. Clinical Trial.
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort.
Ringelstein M, Asseyer S, Lindenblatt G, Fischer K, Pul R, Skuljec J, Revie L, Giglhuber K, Häußler V, Karenfort M, Hellwig K, Paul F, Bellmann-Strobl J, Otto C, Ruprecht K, Ziemssen T, Emmer A, Rothhammer V, Nickel FT, Angstwurm K, Linker R, Laurent SA, Warnke C, Jarius S, Korporal-Kuhnke M, Wildemann B, Wolff S, Seipelt M, Yalachkov Y, Retzlaff N, Zettl UK, Rommer PS, Kowarik MC, Wickel J, Geis C, Hümmert MW, Trebst C, Senel M, Gold R, Klotz L, Kleinschnitz C, Meuth SG, Aktas O, Berthele A, Ayzenberg I; German Neuromyelitis Optica Study Group (NEMOS). Ringelstein M, et al. Among authors: pul r. Neurology. 2024 Nov 12;103(9):e209888. doi: 10.1212/WNL.0000000000209888. Epub 2024 Oct 1. Neurology. 2024. PMID: 39353149 Free PMC article.
Cognitive Impairment, Associated Clinical Factors, and MR Volumetric Measures in Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disease.
Kogel AK, Ladopoulos T, Schwake C, Kleiter I, Teegen B, Siems N, Prehn C, Lichtenberg S, Ringelstein M, Aktas O, Pul R, Krieger B, Lukas C, Penner IK, Gold R, Schneider R, Ayzenberg I. Kogel AK, et al. Among authors: pul r. Neurol Neuroimmunol Neuroinflamm. 2024 Dec;11(6):e200325. doi: 10.1212/NXI.0000000000200325. Epub 2024 Oct 11. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39393044 Free article.
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response.
Teschner VE, Fleck AK, Walter C, Schwarze AS, Eschborn M, Wirth T, Steinberg OV, Schulte-Mecklenbeck A, Lu IN, Herrera-Rivero M, Janoschka C, Lünemann JD, Schwab N, Meyer Zu Hörste G, Varghese J, Gross CC, Pul R, Kleinschnitz C, Mader S, Meinl E, Stoll M, Wiendl H, Klotz L. Teschner VE, et al. Among authors: pul r. Ther Adv Neurol Disord. 2023 Dec 9;16:17562864231211077. doi: 10.1177/17562864231211077. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 38084102 Free PMC article.
Real-world therapy management of patients with multiple sclerosis receiving cladribine tablets beyond year 4 - Results from a German cladribine cohort.
Kowarik MC, Ernst M, Woitschach L, Cepek L, Rau D, Kühnler B, Schlemilch-Paschen S, Grothe C, Schwab M, Jöstingmeyer P, Kleinschnitz C, Pul R. Kowarik MC, et al. Among authors: pul r. Mult Scler Relat Disord. 2024 Aug;88:105704. doi: 10.1016/j.msard.2024.105704. Epub 2024 Jun 7. Mult Scler Relat Disord. 2024. PMID: 38878625 Free article.
110 results